These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 8900688

  • 1. Mycophenolate mofetil.
    Bell J, Ross K.
    ANNA J; 1996 Aug; 23(4):409-10, 413. PubMed ID: 8900688
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [A new immunosuppressor: CellCept].
    Mouly-Bandini A.
    Presse Med; 2001 Jan 20; 30(2):66-7. PubMed ID: 11244816
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Mycophenolate mofetil monitoring: is there evidence that it can improve outcomes?
    Byrne R, Yost SE, Kaplan B.
    Clin Pharmacol Ther; 2011 Aug 20; 90(2):204-6. PubMed ID: 21772295
    [No Abstract] [Full Text] [Related]

  • 6. Mycophenolate mofetil.
    Sievers TM, Rossi SJ, Ghobrial RM, Arriola E, Nishimura P, Kawano M, Holt CD.
    Pharmacotherapy; 1997 Aug 20; 17(6):1178-97. PubMed ID: 9399601
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Mycophenolate mofetil as induction therapy after liver transplantation.
    McDiarmid SV.
    Liver Transpl Surg; 1999 Jul 20; 5(4 Suppl 1):S85-9. PubMed ID: 10431021
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Treatment of recurrent heart rejection with mycophenolate mofetil (RS-61443): initial clinical experience.
    Kirklin JK, Bourge RC, Naftel DC, Morrow WR, Deierhoi MH, Kauffman RS, White-Williams C, Nomberg RI, Holman WL, Smith DC.
    J Heart Lung Transplant; 1994 Jul 20; 13(3):444-50. PubMed ID: 8061021
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cytokine analysis before and after mycophenolate mofetil treatment in renal transplantation.
    Oliveira JG, Sampaio S, Xavier P, Aragão P, Mendes A, Guerra L.
    Transplant Proc; 2000 Dec 20; 32(8):2631-2. PubMed ID: 11134732
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Mechanisms of action of mycophenolate mofetil in preventing chronic rejection.
    Allison AC.
    Transplant Proc; 2002 Nov 20; 34(7):2863-6. PubMed ID: 12431636
    [No Abstract] [Full Text] [Related]

  • 18. Therapeutic drug monitoring of mycophenolates: why make simple things complicated?
    Kuypers DR, van Gelder T.
    Transplant Rev (Orlando); 2011 Apr 20; 25(2):45-6. PubMed ID: 21477747
    [No Abstract] [Full Text] [Related]

  • 19. [2/3 The antimetabolites (azathioprine and mycophenolate)].
    Rave M, Limat S, Woronoff-Lemsi MC.
    Soins; 2007 Apr 20; (717):57-8. PubMed ID: 17877258
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.